Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
7.29
+0.04 (0.55%)
At close: Mar 2, 2026, 4:00 PM EST
7.43
+0.14 (1.92%)
After-hours: Mar 2, 2026, 4:10 PM EST
Adicet Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Adicet Bio stock have an average target of 65.33, with a low estimate of 18 and a high estimate of 128. The average target predicts an increase of 796.16% from the current stock price of 7.29.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 21, 2026.
Analyst Ratings
The average analyst rating for Adicet Bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 3 | 3 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $50 | Strong Buy | Maintains | $9 → $50 | +585.87% | Jan 21, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $128 → $18 | Strong Buy | Maintains | $128 → $18 | +146.91% | Jan 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $64 → $144 | Strong Buy | Maintains | $64 → $144 | +1,875.31% | Nov 7, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $112 → $128 | Strong Buy | Maintains | $112 → $128 | +1,655.83% | Oct 8, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $112 | Strong Buy | Reiterates | $112 | +1,436.35% | Sep 19, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-16.65
from -21.33
EPS Next Year
-12.10
from -16.65
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -12.51 | -8.77 | ||||
| Avg | -16.65 | -12.10 | ||||
| Low | -17.99 | -16.62 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.